StockNews.com assumed coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report published on Sunday. The brokerage issued a sell rating on the biotechnology company’s stock.
Genocea Biosciences Price Performance
Shares of NASDAQ:GNCA opened at $0.00 on Friday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.24. Genocea Biosciences has a 12-month low of $0.00 and a 12-month high of $0.00. The stock has a market capitalization of $5,873.00, a price-to-earnings ratio of 0.00 and a beta of 1.61.
Genocea Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Genocea Biosciences
- How to Start Investing in Real Estate
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How to Evaluate a Stock Before Buying
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- How to Buy Cheap Stocks Step by Step
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for Genocea Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genocea Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.